Substantia nigra lesions in Alzheimer disease and normal aging
- PMID: 7662324
- DOI: 10.1097/00002093-199509020-00001
Substantia nigra lesions in Alzheimer disease and normal aging
Abstract
Clinical and pathological overlap between Alzheimer disease (AD) and Parkinson's disease (PD) has been well described; however, the mechanisms of overlap between these two disorders remain unknown. We retrospectively examined clinical and neuropathological features from 66 individuals participating in the Rochester Alzheimer Disease Center to determine the association of AD with substantia nigra (SN) pathology. SN pathology, identified by a loss of pigmented neurons and the presence of gliosis, pigment-laden macrophages, and Lewy bodies, was blindly scored in 48 AD cases and 18 normal elderly controls. We found moderate or severe pathology in the SN in 2 control brains (11%) and 29 AD brains (60%). The numbers of neocortical and hippocampal neurofibrillary tangles (NFTs) and senile plaques (SPs) were not associated with nigral pathology. There was also no significant association of SN pathology with NFTs or SPs in the striatum, the site to which these neurons project. There was no significant association of increasing SN pathology with aging among AD patients, nor with increasing severity and duration of AD. The signs and symptoms of an extrapyramidal movement disorder were, however, associated with increasing SN pathology. We confirm that pathological lesions in the SN are a common feature of AD and an uncommon feature in normal aging. AD is a significant risk factor for SN lesions and PD, but the pathologic severity of AD, as measured by NFTs and SPs, was not associated with SN lesions.
Similar articles
-
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.Neurology. 2005 Apr 26;64(8):1397-403. doi: 10.1212/01.WNL.0000158423.05224.7F. Neurology. 2005. PMID: 15851730
-
Pathological correlates of extrapyramidal signs in Alzheimer's disease.Ann Neurol. 1997 Mar;41(3):368-74. doi: 10.1002/ana.410410312. Ann Neurol. 1997. PMID: 9066358
-
Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.Acta Neuropathol. 1992;83(3):271-6. doi: 10.1007/BF00296789. Acta Neuropathol. 1992. PMID: 1373022
-
Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?Ann Neurol. 1998 Sep;44(3 Suppl 1):S19-31. doi: 10.1002/ana.410440705. Ann Neurol. 1998. PMID: 9749570 Review.
-
Neuropathological substrates of Alzheimer's disease and Parkinson's disease.J Neural Transm Suppl. 1987;24:109-29. J Neural Transm Suppl. 1987. PMID: 3316494 Review.
Cited by
-
Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.J Alzheimers Dis. 2015;46(1):17-34. doi: 10.3233/JAD-142682. J Alzheimers Dis. 2015. PMID: 25720408 Free PMC article. Review.
-
Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease.Int J Mol Sci. 2022 Oct 28;23(21):13119. doi: 10.3390/ijms232113119. Int J Mol Sci. 2022. PMID: 36361905 Free PMC article.
-
Proprioceptive and olfactory deficits in individuals with Parkinson disease and mild cognitive impairment.Acta Neurol Belg. 2024 Apr;124(2):419-430. doi: 10.1007/s13760-023-02420-w. Epub 2023 Nov 14. Acta Neurol Belg. 2024. PMID: 37962784 Free PMC article.
-
Allopregnanolone and neurogenesis in the nigrostriatal tract.Front Cell Neurosci. 2014 Aug 12;8:224. doi: 10.3389/fncel.2014.00224. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25161608 Free PMC article. Review.
-
Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.Ann Clin Transl Neurol. 2019 Aug;6(8):1423-1434. doi: 10.1002/acn3.50837. Epub 2019 Jul 9. Ann Clin Transl Neurol. 2019. PMID: 31402620 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical